Suppr超能文献

四种胰腺提取物在囊性纤维化中的比较。

Comparison of four pancreatic extracts in cystic fibrosis.

作者信息

Beverley D W, Kelleher J, MacDonald A, Littlewood J M, Robinson T, Walters M P

出版信息

Arch Dis Child. 1987 Jun;62(6):564-8. doi: 10.1136/adc.62.6.564.

Abstract

Four different pancreatin products, Pancrease, Creon, Pancrex V Forte, and Pancreatin Merck, were compared in a random crossover trial in children with cystic fibrosis. The results of our study showed that patients who received Creon and Pancrease had fewer gastrointestinal symptoms than patients who received Pancrex V Forte and Pancreatin Merck. Fat absorption was significantly improved with Pancrease when compared with Pancrex V forte and Pancreatin Merck. Also the fat absorption with Creon was superior to that with Pancrex V Forte. There was no significant difference in fat absorption between Pancrease and Creon. Pancrex V Forte and Pancreatin Merck, or Pancreatin Merck and Creon. Faecal nitrogen content was less with both Creon and Pancrease compared with Pancreatin Merck. Creon and Pancrease allow the patient with cystic fibrosis to take a high energy diet without any dietary restrictions.

摘要

在一项针对囊性纤维化儿童的随机交叉试验中,对四种不同的胰酶产品(胰酶肠溶胶囊、得每通、强力胰酶片和默克胰酶)进行了比较。我们的研究结果表明,接受得每通和胰酶肠溶胶囊的患者胃肠道症状比接受强力胰酶片和默克胰酶的患者少。与强力胰酶片和默克胰酶相比,胰酶肠溶胶囊能显著改善脂肪吸收。而且得每通的脂肪吸收也优于强力胰酶片。胰酶肠溶胶囊和得每通之间的脂肪吸收没有显著差异。强力胰酶片与默克胰酶之间,或默克胰酶与得每通之间也无显著差异。与默克胰酶相比,得每通和胰酶肠溶胶囊的粪便氮含量更低。得每通和胰酶肠溶胶囊使囊性纤维化患者能够在没有任何饮食限制的情况下摄入高能量饮食。

相似文献

3
In vivo and in vitro studies of microsphere pancreatic supplements.微球胰腺补充剂的体内和体外研究。
J Pediatr Gastroenterol Nutr. 1988;7 Suppl 1:S22-9. doi: 10.1097/00005176-198811001-00006.
4
Two enteric coated microspheres in cystic fibrosis.囊性纤维化中的两种肠溶微球。
Arch Dis Child. 1990 Jun;65(6):594-7. doi: 10.1136/adc.65.6.594.
7
Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Aliment Pharmacol Ther. 1994 Dec;8(6):603-7. doi: 10.1111/j.1365-2036.1994.tb00337.x.

引用本文的文献

1
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD008227. doi: 10.1002/14651858.CD008227.pub4.
2
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD008227. doi: 10.1002/14651858.CD008227.pub3.
5
Control of malabsorption in cystic fibrosis.囊性纤维化中吸收不良的控制
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
7
Update on intestinal strictures.肠道狭窄的最新情况。
J R Soc Med. 1999;92 Suppl 37(Suppl 37):41-9. doi: 10.1177/014107689909237S08.
8
Uses and abuses of enzyme therapy in cystic fibrosis.酶疗法在囊性纤维化中的应用与滥用
J R Soc Med. 1998;91 Suppl 34(Suppl 34):2-13. doi: 10.1177/014107689809134s02.
10
Nutritional management of cystic fibrosis.囊性纤维化的营养管理。
Arch Dis Child. 1996 Jan;74(1):81-7. doi: 10.1136/adc.74.1.81.

本文引用的文献

8
Iatrogenic hyperuricemia in children with cystic fibrosis.
J Pediatr. 1978 Dec;93(6):976-8. doi: 10.1016/s0022-3476(78)81225-6.
9
An enteric-coated pancreatic enzyme preparation that works.
Dig Dis Sci. 1979 Dec;24(12):906-9. doi: 10.1007/BF01311943.
10
Host defense in malnutrition.
Pediatrics. 1977 Apr;59(4):490-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验